Evidence map›Paper›PMID 32456163›Full record

ArticlePharmaceutics2020

Optimization of Curcumin Nanocrystals as Promising Strategy for Nose-to-Brain Delivery Application.

Angela Bonaccorso, Maria Rosa Gigliobianco, Rosalia Pellitteri, Debora Santonocito, Claudia Carbone, Piera Di Martino, Giovanni Puglisi, Teresa Musumeci

Erratum issuedAbstract read
In one paragraph

Article in Pharmaceutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. SoluplusDrug delivery and translational research · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Angela BonaccorsoDepartment of Drug Sciences, University of Catania; V.le Andrea Doria, 6, 95125 Catania, Italy.ORCID 0000-0002-3392-1258
Maria Rosa GigliobiancoSchool of Pharmacy, University of Camerino, Via. S. Agostino 1, 62032 Camerino (MC), Italy.ORCID 0000-0002-9699-4673
Rosalia PellitteriInstitute for Biomedical Research and Innovation, National Research Council, Via Paolo Gaifami 18, 95126 Catania, Italy.
Debora SantonocitoDepartment of Drug Sciences, University of Catania; V.le Andrea Doria, 6, 95125 Catania, Italy.
Claudia CarboneDepartment of Drug Sciences, University of Catania; V.le Andrea Doria, 6, 95125 Catania, Italy.ORCID 0000-0003-3592-752X
Piera Di MartinoSchool of Pharmacy, University of Camerino, Via. S. Agostino 1, 62032 Camerino (MC), Italy.ORCID 0000-0002-7657-3556
Giovanni PuglisiDepartment of Drug Sciences, University of Catania; V.le Andrea Doria, 6, 95125 Catania, Italy.
Teresa MusumeciDepartment of Drug Sciences, University of Catania; V.le Andrea Doria, 6, 95125 Catania, Italy.

Funding

Research Funding for University of Catania, under Project Piano per la Ricerca 2016-2018 - Linea Di Intervento 2 "Dotazione Ordinaria" cod. 57722172106.
6 · The paper itself

Abstract

Intranasal (IN) drug delivery is recognized to be an innovative strategy to deliver drugs to the Central Nervous System. One of the main limitations of IN dosing is the low volume of drug that can be administered. Accordingly, two requirements are necessary: the drug should be active at a low dosage, and the drug solubility in water must be high enough to accommodate the required dose. Drug nanocrystals may overcome these limitations; thus, curcumin was selected as a model drug to prepare nanocrystals for potential IN administration. With this aim, we designed curcumin nanocrystals (NCs) by using Box Behnken design. A total of 51 formulations were prepared by the sonoprecipitation method. Once we assessed the influence of the independent variables on nanocrystals' mean diameter, the formulation was optimized based on the desirability function. The optimized formulation was characterized from a physico-chemical point of view to evaluate the mean size, zeta potential, polidispersity index, pH, osmolarity, morphology, thermotropic behavior and the degree of crystallinity. Finally, the cellular uptake of curcumin and curcumin NCs was evaluated on Olfactory Ensheathing Cells (OECs). Our results showed that the OECs efficiently took up the NCs compared to the free curcumin, showing that NCs can ameliorate drug permeability.

Indexed as

amorphismbottom-upBox Behnken designcrystallinityexperimental designnatural compoundolfactory ensheathing cellsresponse surface methodologysonoprecipitation

Identifiers

PMID32456163
PMCPMC7284456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.